Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2023

MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M

Posted on November 27, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has closed its previously announced public offering. The offering was comprised of 5,384,615 shares of common stock (or common stock equivalents in lieu thereof) and warrants; the … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces Third-Quarter Financial Highlights, Voices Support for Expanded National Quantum Initiative

Posted on November 27, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and services, recently announced financial results for its fiscal third quarter, which ended September 30, 2023. D-Wave CEO Dr. Alan Baratz believes this is a pivotal moment in … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview

Posted on November 22, 2023 by MissionIR

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, was featured in a recent Proactive interview. Mark Dybul, CEO of Renovaro, joined host Steve Darling to talk … Continue reading →

Posted in Renovaro BioSciences Inc. RENB | Leave a comment

MissionIRNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Issues Warning to Shareholders

Posted on November 22, 2023 by MissionIR

Safety Shot (NASDAQ: SHOT) today announced that it has come to its attention that there are several disclosed short sellers publishing malicious defamatory, inaccurate articles about Safety Shot and its management in a willful attempt to scare SHOT investors out … Continue reading →

Posted in Safety Shot Inc. SHOT | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Updated Safety Data from Berubicin Study at SNO Annual Gathering

Posted on November 22, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced the presentation of updated safety data from its ongoing potentially pivotal study … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer

Posted on November 22, 2023 by MissionIR

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes, was granted orphan drug designation (“ODD”) by the US Food and Drug Administration (“FDA”) for its REQORSA(R) immunogene therapy for … Continue reading →

Posted in Small Cap News | Leave a comment

Clene Inc. (NASDAQ: CLNN) Capitalizing on the Promising Chemical and Therapeutic Properties of Nanocrystals to Address High Unmet Medical Needs

Posted on November 22, 2023 by MissionIR

Nanotechnology has attracted a great deal of the scientific community’s attention thanks to its ability to deliver medicinally attractive nanoparticles (“NPs”) with promising performances that are directly attributable to such properties as ease of cellular uptake, stability, solubility, synthetic accessibility, … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases, Harness Cutting-Edge AI Technology

Posted on November 21, 2023 by MissionIR

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy, recently announced a definitive agreement to combine with the advanced AI company GEDiCube International Ltd, rebranding as Renovaro AI. “The company has also announced the addition … Continue reading →

Posted in Renovaro BioSciences Inc. RENB | Leave a comment

MissionIRNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) GM Featured Guest on Latest Bell2Bell Podcast Release

Posted on November 21, 2023 by MissionIR

Turbo Energy S.A. (NASDAQ: TURB), a leading photovoltaic energy-storage technology company based in Valencia, Spain, is featured in a recent episode of IBN’s The Bell2Bell Podcast. According to the announcement, Turbo Energy general manager Mariano Soria joined host Stuart Smith … Continue reading →

Posted in Turbo Energy S.A. TURB) | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Makes Visionary Pitch for Domestic REE Supply Chain at Fall Mining Showcase 2023

Posted on November 21, 2023 by MissionIR

Strategic metals supply chain-focused enterprise Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is driving American hemisphere innovation in the rare earth element (“REE”) market as a means of protecting Western inventions and technological applications from becoming too vulnerable to The People’s Republic … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment